Patent Number | Title | Applicant | Opposition Date |
---|---|---|---|
EP3697392 | Tablets Comprising Tamsulosin And Solifenacin | SYNTHON B.V. | Aug 13, 2024 |
EP3641819 | Use Of Cannabidiol In The Treatment Of Tuberous Sclerosis Complex | GW RESEARCH LIMITED | Jul 9, 2024 |
EP3542790 | Compositions Comprising A Delivery Agent And Preparation Thereof | NOVO NORDISK A/S | Jun 13, 2024 |
EP3728313 | Combination Anti Cancer Therapy With An Iap Antagonist And An Anti Pd-1 Molecule | DEBIOPHARM INTERNATIONAL SA | Apr 30, 2024 |
EP3604299 | Chemical Compound Useful As Intermediate For Preparing A Catechol-0-Methyl Transferase Inhibitor | BIAL-PORTELA & CA, S.A. | Apr 26, 2024 |
EP3746111 | Solid Compositions Comprising A Glp-1 Agonist, A Salt Of N-(8-(2-Hydroxybenzoyl)Amino)Caprylic Acid And A Lubricant | NOVO NORDISK A/S | Apr 18, 2024 |
EP2691157 | Isopentyl Esters For The Use In Cosmetic, Dermatological, Or Pharmaceutical Compositions | EVONIK DEGUSSA GMBH | Mar 7, 2024 |
EP3714751 | Holder For Paper Roll And Tamper-Proof End Piece For Paper Roll | PAREDES FAB | Mar 6, 2024 |
EP3810201 | Gip/Glp1 Agonist Compositions | ELI LILLY AND COMPANY | Mar 5, 2024 |
EP2508188 | Pharmaceutical Formulations Containing Dapagliflozin Propylene Glycol Hydrate | ASTRAZENECA AB | Feb 9, 2024 |
Feel free to send us a message here and we will get back to you